Correlation Between VIRI Old and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both VIRI Old and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VIRI Old and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VIRI Old and Biodexa Pharmaceticals, you can compare the effects of market volatilities on VIRI Old and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VIRI Old with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of VIRI Old and Biodexa Pharmaceticals.
Diversification Opportunities for VIRI Old and Biodexa Pharmaceticals
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between VIRI and Biodexa is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding VIRI Old and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and VIRI Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VIRI Old are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of VIRI Old i.e., VIRI Old and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between VIRI Old and Biodexa Pharmaceticals
Given the investment horizon of 90 days VIRI Old is expected to under-perform the Biodexa Pharmaceticals. But the stock apears to be less risky and, when comparing its historical volatility, VIRI Old is 1.42 times less risky than Biodexa Pharmaceticals. The stock trades about -0.02 of its potential returns per unit of risk. The Biodexa Pharmaceticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 3,375 in Biodexa Pharmaceticals on November 3, 2024 and sell it today you would lose (2,934) from holding Biodexa Pharmaceticals or give up 86.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 86.29% |
| Values | Daily Returns |
VIRI Old vs. Biodexa Pharmaceticals
Performance |
| Timeline |
| VIRI Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Biodexa Pharmaceticals |
VIRI Old and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VIRI Old and Biodexa Pharmaceticals
The main advantage of trading using opposite VIRI Old and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VIRI Old position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.| VIRI Old vs. LMF Acquisition Opportunities | VIRI Old vs. ZyVersa Therapeutics | VIRI Old vs. Sonnet Biotherapeutics Holdings | VIRI Old vs. Revelation Biosciences |
| Biodexa Pharmaceticals vs. Molecular Partners AG | Biodexa Pharmaceticals vs. Southwest Airlines | Biodexa Pharmaceticals vs. American Airlines Group | Biodexa Pharmaceticals vs. Allegiant Travel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |